申请人:Calderini Michel
公开号:US20120115861A1
公开(公告)日:2012-05-10
Compounds of the formula (I), in which R
1
, R
2
, R
3
, R
4
, R
7
and Y have the meanings indicated in Claim
1
, are inhibitors of PDK1 and cell proliferation/cell vitality and can be employed for the treatment of tumours and for the treatment of inflammatory diseases.
化合物的结构式(I),其中R1、R2、R3、R4、R7和Y具有权利要求1中指示的含义,是PDK1和细胞增殖/细胞活力的抑制剂,可用于肿瘤的治疗和炎症性疾病的治疗。